Dr. Fang is currently Professor and Chief surgeon of Thoracic Surgery and of Respiratory Surgery at Shanghai Chest Hospital and Honorary Chair of Mediastinal Tumor Committee of Chinese Anti-Cancer Association, China. He is a member of IASLC, serving at the Staging and Prognostic Factor Committee and the Multidisciplinary Clinical Science Committee. He is also a member of the AATS, and committee member at the EACTS and the ASCVTS thoracic domain.
Dr. Fang has a full range of practice in surgical management of pulmonary, mediastinal, and esophageal diseases. His expertise lies mainly in minimally invasive surgery and multimodality treatment of thoracic oncology, including lung cancers, esophageal cancers, and mediastinal tumors.
His research interests focus on surgery in the multidisciplinary treatment of thoracic malignancies, particularly innovation in surgery and treatment modalities, disease mechanisms, and development of novel drugs.
Dr. Fang has also been actively involved in educational activities, including acting as the director for resident and fellowship programs as well as the Royal College of Surgeons advanced VATS training program at the Shanghai Chest Hospital.